On Nov 05, major Wall Street analysts update their ratings for $Illumina (ILMN.US)$, with price targets ranging from $177 to $254.
Citi analyst Patrick B Donnelly maintains with a buy rating, and adjusts the target price from $155 to $190.
TD Cowen analyst Daniel Brennan maintains with a buy rating, and adjusts the target price from $144 to $177.
RBC Capital analyst Conor McNamara maintains with a buy rating, and adjusts the target price from $252 to $254.
Piper Sandler analyst David Westenberg maintains with a buy rating, and maintains the target price at $195.
Furthermore, according to the comprehensive report, the opinions of $Illumina (ILMN.US)$'s main analysts recently are as follows:
The company's Q4 revenue guidance was marginally below consensus, yet the outlook remains positive due to Illumina's potential for margin expansion and management's emphasis on operational leverage.
The firm notes that the solid quarter-over-quarter NSX consumables growth indicates an ongoing demand for the 25B flowcell.
Illumina delivered a third-quarter performance that surpassed expectations, with its Service segment leading the way, even though there was a shortfall in X placements. Margins on gross profit and EBIT showed substantial outperformance. The forecast for 2024 was slightly reduced, while the projections for EPS were adjusted upwards.
Here are the latest investment ratings and price targets for $Illumina (ILMN.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間11月5日，多家華爾街大行更新了$Illumina (ILMN.US)$的評級，目標價介於177美元至254美元。
花旗分析師Patrick B Donnelly維持買入評級，並將目標價從155美元上調至190美元。
TD Cowen分析師Daniel Brennan維持買入評級，並將目標價從144美元上調至177美元。
加皇資本市場分析師Conor McNamara維持買入評級，並將目標價從252美元上調至254美元。
派傑投資分析師David Westenberg維持買入評級，維持目標價195美元。
此外，綜合報道，$Illumina (ILMN.US)$近期主要分析師觀點如下：
公司Q4營業收入預測略低於共識，但由於illumina潛力擴大毛利潤和管理層強調運營槓桿，展望仍然積極。
該公司指出，季度間NSX耗材增長強勁，表明對250億流式細胞的需求持續存在。
illumina在第三季度表現超出預期，其服務部門處於領先地位，儘管X放置數量有所不足。毛利潤和EBIt的利潤率表現顯著超前。2024年的預測略有下調，而每股收益方面的預測則有所上調。
以下爲今日4位分析師對$Illumina (ILMN.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
